Models of bone metastasis

Journal of Visualized Experiments

Volumn , Issue 67, 2012, Pages

  Preston Campbell, J ^a,b   Merkel, Alyssa R ^b,c,d   Kathryn Masood Campbell, S ^b,d   Elefteriou, Florent ^a,b,d   Sterling, Julie A ^b,c,d  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^c DEPARTMENT OF VETERANS AFFAIRS   (United States)

^d VANDERBILT UNIVERSITY   (United States)

Author keywords

Breast cancer; Cancer biology; Intracardiac injections; Intratibial injections; Issue 67; Medicine; Mouse models of bone metastasis; Tumor cells

Indexed keywords

EID: 84868291376     PISSN: 1940087X     EISSN: None     Source Type: Journal    
DOI: 10.3791/4260     Document Type: Article

References (13)

1. Sterling, J.A., Edwards, J.R., Martin, T.J., & Mundy, G.R. Advances in the biology of bone metastasis: how the skeleton affects tumor behavior. Bone. 48, 6-15, doi:S8756-3282(10)01358-X [pii]10.1016/j.bone.2010.07.015 (2011).
2. Yoneda, T., Sasaki, A., & Mundy, G.R. Osteolytic bone metastasis in breast cancer. Breast Cancer Res. Treat. 32, 73-84 (1994).
3. Johnson, R.W., et al. TGF-beta promotion of Gli2-induced expression of parathyroid hormone-related protein, an important osteolytic factor in bone metastasis, is independent of canonical Hedgehog signaling. Cancer Res. 71, 822-831, doi:0008-5472.CAN-10-2993 [pii]10.1158/0008-5472.CAN-10-2993 (2011).
4. Li, X., et al. Loss of TGF-beta Responsiveness in Prostate Stromal Cells Alters Chemokine Levels and Facilitates the Development of Mixed Osteoblastic/Osteolytic Bone Lesions. Mol. Cancer Res. doi:1541-7786.MCR-11-0506 [pii]10.1158/1541-7786.MCR-11-0506 (2012).
5. Yoneda, T., et al. Actions of bisphosphonate on bone metastasis in animal models of breast carcinoma. Cancer. 88, 2979-2988, doi:10.1002/1097-0142(20000615)88:12+<2979::AID-CNCR13>3.0.CO;2-U [pii] (2000).
6. Rose, A.A., et al. Osteoactivin promotes breast cancer metastasis to bone. Mol. Cancer Res. 5, 1001-1014, doi:5/10/1001 [pii]10.1158/1541-7786.MCR-07-0119 (2007).
7. Sterling, J.A., et al. The hedgehog signaling molecule Gli2 induces parathyroid hormone-related peptide expression and osteolysis in metastatic human breast cancer cells. Cancer Res. 66, 7548-7553, doi:66/15/7548 [pii]10.1158/0008-5472.CAN-06-0452 (2006).
8. Lu, X., et al. VCAM-1 promotes osteolytic expansion of indolent bone micrometastasis of breast cancer by engaging alpha4beta1-positive osteoclast progenitors. Cancer Cell. 20, 701-714, doi:S1535-6108(11)00408-9 [pii]10.1016/j.ccr.2011.11.002 (2011).
9. Oyajobi, B.O., et al. Detection of myeloma in skeleton of mice by whole-body optical fluorescence imaging. Mol. Cancer Ther. 6, 1701-1708, doi:1535-7163.MCT-07-0121 [pii]10.1158/1535-7163.MCT-07-0121 (2007).
10. Johnson, L.C., et al. Longitudinal live animal micro-CT allows for quantitative analysis of tumor-induced bone destruction. Bone. 48, 141-151, doi:S8756-3282(10)01284-6 [pii]10.1016/j.bone.2010.05.033 (2011).
11. Sterling, J. & Johnson, R. In Imaging Techniques for the Detection and Examination of Breast Cancer Metastasis to Bone. Vol. 46, Nova Science Publishers, (2011).
12. Steinbauer, M., et al. GFP-transfected tumor cells are useful in examining early metastasis in vivo, but immune reaction precludes long-term tumor development studies in immunocompetent mice. Clin. Exp. Metastasis. 20, 135-141 (2003).
13. Oyajobi, B.O., et al. Dual effects of macrophage inflammatory protein-1alpha on osteolysis and tumor burden in the murine 5TGM1 model of myeloma bone disease. Blood. 102, 311-319, doi:10.1182/blood-2002-12-39052002-12-3905 [pii] (2003).